Applied Statistics
Inaugural Antibody Drug Products
Hotel Del Coronado
1500 Orange Ave.
Coronado, California
Revolutionizing Therapeutics

Antibody-based products currently revolutionizing therapeutics will be addressed, including antibody-drug conjugates, bispecific antibodies, and other novel constructs.
These new antibody designs are overcoming nagging challenges, such as size and penetration, and enhancing half-life, PK, and specificity. Join colleagues
from around the world in this discussion of the exciting breakthroughs made possible by engineering advances, and see how cancer and other applications are
progressing into a true therapeutic revolution.

Schedule of Presentations:

Thursday, January 13, 2011
13:00:00 Conference Registration
13:40:00 Innovating the Design of Antibody Therapeutics
13:45:00 Chairperson’s Opening Remarks
13:50:00 Opening Keynote Speaker | Synthetic Polymers with Antibody-Like Affinity that Function in vitro and in vivo Kenneth Shea
14:20:00 Drug Conjugation Site Modulates the Stability and Biological Activity of Antibody Drug Conjugates Ben Shen
14:50:00 Innovative Strategies and Techniques for Late Stage Screening of Therapeutic Biologics Mohan Srinivasan
15:20:00 Sponsored Presentation
15:35:00 Refreshment Break | Exhibit and Poster Viewing
16:25:00 Engineering Multi-Specificity
16:30:00 Advances in the Pre-Clinical Development of IgG-Like Bispecific Antibodies Scott M Glaser
17:00:00 Dual-Affinity Re-Targeting (DART) Proteins: Production, Applications, and Platform Optimization Syd Johnson
17:30:00 TRIBODY™ | A Platform for Novel Antibody-Derived Biopharmaceuticals Nico Mertens
18:00:00 Close of Day
Friday, January 14, 2011
07:30:00 Breakfast Presentation | Coffee
08:15:00 Chairperson’s Opening Remarks
08:20:00 Development of Antibody-Drug Conjugate Technology Based on Novel Linkers & DNA Alkylating Duocarmycins Vincent de Groot
08:50:00 Targeting Chemotherapy to Prostate Cancer and the Neovasculature of Other Solid Tumors with PSMA ADC William C. Olson
09:20:00 Antibody-Maytansinoid Conjugates: Revolutionary Drug Products for Treating Cancer John M. Lambert
09:50:00 Sponsored Presentation
10:05:00 Coffee Break | Exhibit and Poster Viewing
10:45:00 Poster Awards | Exhibit Hall
11:00:00 Arming a TCell Platform with Bispecific Antibodies for Cancer & Infectious Diseases Lawrence G. Lum
11:30:00 Recombinant Bispecific Antibodies for Cancer Immunotherapy Roland Kontermann
12:00:00 TCell-Mediated Lysis of Cancer Cells by BiTE Antibodies Roman Kischel
12:30:00 Close of Morning Session
12:45:00 Luncheon Presentations | or Lunch on Your Own
13:55:00 Novel Approaches and Constructs
14:00:00 Chairperson’s Remarks
14:05:00 The Story of One Antibody Drug Product in Multiple Cancers Omid Hamid
14:35:00 Perspectives on Targeted RNases as Therapeutics Susanna M. Rybak
15:05:00 CovX-Bodies: A New Scaffold for Antibody Conjugates Joel Desharnais
15:35:00 Foldit | Video Games for Scientific Discovery in Biochemistry Seth Cooper
16:05:00 End of Conference
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.